Screener
Spyre Therapeutics, Inc. SYRE Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Spyre Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001636282-26-000050
FAQ
- What is Spyre Therapeutics, Inc.'s price / book?
- Spyre Therapeutics, Inc. (SYRE) reported price / book of 5.9× in Q1 2026.
- How has Spyre Therapeutics, Inc.'s price / book changed year-over-year?
- Spyre Therapeutics, Inc.'s price / book increased by 193.1% year-over-year, from 2× to 5.9×.
- What is the long-term trend for Spyre Therapeutics, Inc.'s price / book?
- Over 5 years (2020 to 2025), Spyre Therapeutics, Inc.'s price / book has grown at a 3.4% compound annual growth rate (CAGR), from 3× to 3.6×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Spyre Therapeutics, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude